Osteomalacia: Clinical Trials

34 trials for Osteomalacia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

25 completed, 4 unknown, 2 recruiting, 1 approved for marketing. 10 Phase 2, 6 Phase 1, 2 Not applicable, 2 Phase 3, 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 210Completed 9, Withdrawn 1
Phase 16Completed 5, Terminated 1
Not applicable2Completed 1, Unknown 1
Phase 32Completed 2
Phase 42Completed 2

Follow Osteomalacia: new trials by email Literature Review of Osteomalacia trials Research Report on Osteomalacia

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Post Marketing Surveillance Study to Observe Safety and Effectiveness of CRYSVITA® in S. Korean Patients
FGF23-related hypophosphataemic rickets and osteomalacia - FGF23-related Hypophosphataemic Rickets and Osteomalacia
RecruitingKyowa Kirin Korea Co., Ltd.1002023-08-112025-08-29
Serum Prolidase Activity and the Role of Leptin in Osteomalacia
Vitamin D - Osteomalacia
Not applicableUnknownTUĞBA ŞAHBAZ382023-02-152023-02-14
Burosumab for Fibroblast Growth Factor-23 Mediated Hypophosphatemia in Fibrous Dysplasia
Burosumab - Fibrous Dysplasia Of Bone
Phase 2CompletedNational Institute of Dental and Craniofacial Research (NIDCR)122022-12-072026-02-02
Calcium-phosphate Complications Induced by IV Iron Supplementation in Patients With Rendu-Osler Disease
Rendu Osler Disease
UnknownUniversity Hospital, Strasbourg, France2202022-08-012023-12-19
Dental Implants Rehabilitation in Patients With Vitamin D3 Imbalance
Dental implantation - Tooth Loss, Vitamin D3 Deficiency
Not applicableCompletedI.M. Sechenov First Moscow State Medical University3842021-04-102022-08-12
Study of the Diagnostic Value of Hybrid PET/MR and PET/CT in Neuroendocrine Diseases and Tumor Induced Osteomalacia
68Ga-DOTA-TATE PET/MR and PET/CT imaging - PET / CT, PET / MR
UnknownUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology602019-05-052023-02-14
Ga-DOTATATE PET for Phosphaturic Mesenchymal Tumors in Patients With Tumor Induced Osteomalacia
68Ga-DOTATATE PET/CT - Osteomalacia
Phase 1 / Phase 2CompletedMayo Clinic182019-01-312025-04-30
A Study of KRN23 in Pediatric Patients With X-linked Hypophosphatemic Rickets/Osteomalacia
KRN23 - X-linked Hypophosphatemic Rickets/Osteomalacia
Phase 3CompletedKyowa Kirin Co., Ltd.162017-07-062022-09-06
Post-approval Clinical Study of Asfotase Alfa Treatment for Patients With Hypophosphatasia (HPP) in Japan
Asfotase Alfa - Hypophosphatasia
Phase 4CompletedAlexion Pharmaceuticals, Inc.132015-06-012017-05-08
Study of the Diagnostic Value of Stable Calcium Isotope Profiling in Bone and Calcium Disorders
Bone Diseases, Osteomalacia
CompletedUniversitaire Ziekenhuizen KU Leuven542014-10-012020-11-06
Non-interventional Substudy of ALX-HPP-502 to Assess Natural History of Patients With Juvenile-onset HPP Who Served as Historical Controls in ENB-006-09
Retrospective Case Only - Hypophosphatasia, Bone Disease
CompletedAlexion Pharmaceuticals, Inc.62014-08-012019-03-13
A Study of KRN23 in Subjects With X-linked Hypophosphatemic Rickets/Osteomalacia
KRN23 - X-linked Hypophosphatemic Rickets/Osteomalacia
Phase 1CompletedKyowa Kirin Co., Ltd.152014-07-012017-03-03
Retrospective, Non-interventional Natural History of Patients With Juvenile-onset Hypophosphatasia (HPP)
Hypophosphatasia (HPP)
CompletedAlexion Pharmaceuticals, Inc.322014-03-012019-04-01
COMPREHENSIVE® REVERSE SHOULDER Mini BasePlate
COMPREHENSIVE - Rotator Cuff Tear Arthropathy, Osteoporosis
CompletedZimmer Biomet1002013-12-012019-07-05
Cinacalcet for Fibroblast Growth Factor 23 (FGF23)-Mediated Hypophosphatemia (Hypophosphatemic Rickets)
Osteomalacia - Osteomalacia
Phase 1TerminatedNational Institute of Dental and Craniofacial Research (NIDCR)12012-11-162018-07-05
A Retrospective Study of the Natural History of Patients With Severe Perinatal and Infantile Hypophosphatasia (HPP)
Hypophosphatasia (HPP)
CompletedAlexion Pharmaceuticals, Inc.482012-08-012019-04-01
Serum Sclerostin Level & Treatment of Vitamin D Deficiency
Endocrine System Diseases, Vitamin D Deficiency
CompletedBagcilar Training and Research Hospital262012-03-012014-12-23
Development of a Non-invasive Assessment of Human Bone Quality Using Spatially Offset Raman Spectroscopy
spatially offset Raman spectrometer (SORS) - Osteoarthritis, Osteoporosis
UnknownUniversity College, London2452011-10-012022-11-23
Open-Label Study of Asfotase Alfa in Infants and Children ≤ 5 Years of Age With Hypophosphatasia (HPP)
asfotase alfa - Hypophosphatasia
Phase 2 / Phase 3CompletedAlexion Pharmaceuticals, Inc.692010-07-012019-03-13
Safety and Efficacy Study of Asfotase Alfa in Adolescents and Adults With Hypophosphatasia (HPP)
asfotase alfa - Hypophosphatasia
Phase 2CompletedAlexion Pharmaceuticals, Inc.192010-06-012019-03-13

Showing 20 of 34. Sign in to see all of them.

Narrower conditions

Rickets (17)  ·  Bone Diseases (14)  ·  Hypophosphatasia (13)  ·  Osteoporosis (6)  ·  Vitamin D Deficiency (3)  ·  Bone Diseases, Metabolic (2)  ·  Familial Hypophosphatemic Rickets (2)  ·  Hypophosphatemia (2)  ·  Oncogenic osteomalacia (2)  ·  Endocrine System Diseases (1)  ·  Fibrous Dysplasia of Bone (1)  ·  Fibrous Dysplasia, Polyostotic (1)  ·  Hyperparathyroidism, Secondary (1)  ·  Hypocalcemia (1)

Broader conditions

Avitaminosis (34)  ·  Calcium Metabolism Disorders (34)  ·  Deficiency Diseases (34)  ·  Malnutrition (34)  ·  Metabolic Diseases (34)  ·  Musculoskeletal Diseases (34)  ·  Nutrition Disorders (34)  ·  Nutritional and Metabolic Diseases (34)  ·  Bone Diseases, Metabolic (32)  ·  Vitamin D Deficiency (31)  ·  Bone Diseases (20)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (18)  ·  Genetic Diseases, Inborn (17)  ·  Rickets (17)  ·  Metabolism, Inborn Errors (16)

Interventions

asfotase alfa (10)  ·  burosumab (3)  ·  Blood Specimen Collection (1)  ·  Calcium (1)  ·  Cholecalciferol (1)  ·  Comprehensive Metabolic Panel (1)  ·  Dental Implantation (1)  ·  Vitamin D (1)

Sponsors

Alexion Pharmaceuticals, Inc. (13)  ·  National Institute of Dental and Craniofacial Research (NIDCR) (4)  ·  Kyowa Kirin Co., Ltd. (2)  ·  Bagcilar Training and Research Hospital (1)  ·  Clalit Health Services (1)  ·  I.M. Sechenov First Moscow State Medical University (1)  ·  Istanbul University (1)  ·  Kyowa Kirin Korea Co., Ltd. (1)  ·  Mayo Clinic (1)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1)  ·  TUĞBA ŞAHBAZ (1)  ·  Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (1)  ·  Universitaire Ziekenhuizen KU Leuven (1)  ·  University College, London (1)  ·  University Hospital, Strasbourg, France (1)

Countries

United States (17)  ·  Canada (8)  ·  United Kingdom (5)  ·  France (4)  ·  Turkey (Türkiye) (4)  ·  Australia (3)  ·  Germany (3)  ·  Japan (3)  ·  Russia (3)  ·  South Korea (3)  ·  Spain (2)  ·  United Arab Emirates (2)  ·  Belgium (1)  ·  China (1)  ·  Denmark (1)

Top investigators

Alison M Boyce, M.D. (1)  ·  Anat Tsur, MD (1)  ·  Andrew Denker, MD, PhD (1)  ·  Dirk Vanderschueren, MD, PhD (1)  ·  Ekaterina Diachkova, PhD (1)  ·  HaeMi Park (1)  ·  Helen Birch, Professor (1)  ·  Jae Chul Yoo, Ph. D. (1)  ·  Joo Han Oh, Ph.D. (1)  ·  Kelly B Roszko, M.D. (1)  ·  Kenji Fujita, MD (1)  ·  Kyu Chul Noh, Ph.D. (1)  ·  Lars Rejnmark, Professor (1)  ·  Lee S Weinstein, M.D. (1)

Results publications

PMID 26529632, PMID 32417537, PMID 32762706, PMID 27699270, PMID 19244376, PMID 22397652, PMID 24120120, PMID 26675779, PMID 30558909, PMID 30811537, PMID 30969260, PMID 33257353, PMID 35854274, PMID 36719566, PMID 39151033